A DOUBLE-BLIND RANDOMIZED CROSSOVER TRIAL OF BROMOCRIPTINE AND PLACEBO IN RESTLESS LEGS SYNDROME

被引：159
|
作者：
WALTERS, AS
HENING, WA
KAVEY, N
CHOKROVERTY, S
GIDROFRANK, S
机构：
[1] VET ADM MED CTR,NEUROL SERV,NEUROPHYSIOL SECT,LYONS,NJ 07939
[2] COLUMBIA PRESBYTERIAN MED CTR,CTR SLEEP DISORDERS,NEW YORK,NY 10032
来源：
ANNALS OF NEUROLOGY | 1988年 / 24卷 / 03期
关键词：
D O I：
10.1002/ana.410240318
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：455 / 458
页数：4
相关论文
共 50 条
  • [31] TREATMENT OF RESTLESS LEGS SYNDROME WITH PREGABALIN: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY Reply
    Garcia-Borreguero, Diego
    Williams, Anne-Marie
    Larrosa, Oscar
    NEUROLOGY, 2011, 76 (04) : 408 - 409
  • [32] Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study
    Weinstock, Leonard B.
    Zeiss, Suzie
    SLEEP AND BIOLOGICAL RHYTHMS, 2012, 10 (02) : 145 - 153
  • [33] Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study
    Leonard B. Weinstock
    Suzie Zeiss
    Sleep and Biological Rhythms, 2012, 10 : 145 - 153
  • [34] Bright light therapy in restless legs syndrome: a double-blind, placebo-controlled study
    Kilic-Huck, U.
    Meyer, C.
    Ruppert, E.
    Chambe, J.
    Bataillard, M.
    Schroder, C.
    Bourgin, P.
    JOURNAL OF SLEEP RESEARCH, 2014, 23 : 312 - 313
  • [35] A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of XP13512/GSK1838262 in the Treatment of Patients With Primary Restless Legs Syndrome
    Kushida, Clete A.
    Walters, Arthur S.
    Becker, Philip
    Thein, Stephen G.
    Perkins, Thomas
    Roth, Thomas
    Canafax, Daniel
    Barrett, Ronald W.
    SLEEP, 2009, 32 (02) : 159 - 168
  • [36] DHEA on Sexual Function in Sheehan Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial
    Mandal, Soumita
    Mukhopadhyay, Pradip
    Ghosh, Sujoy
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08): : E3395 - E3402
  • [37] Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Walters, Arthur S.
    Ondo, William G.
    Kushida, Clete A.
    Becker, Philip M.
    Ellenbogen, Aaron L.
    Canafax, Daniel M.
    Barrett, Ronald W.
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (06) : 311 - 320
  • [38] Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa
    Staedt, J
    Wassmuth, F
    Ziemann, U
    Hajak, G
    Ruther, E
    Stoppe, G
    JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (4-5) : 461 - 468
  • [39] A Comparative study on the effects of vitamin C and Pramipexole on restless legs syndrome treatment in hemodialysis patients: A randomized, double-blind, placebo-controlled trial
    Rafie, Shahram
    Jafari, Majid
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2016, 5 (02): : 128 - 134
  • [40] Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest)
    Richards, Kathy
    Morrison, Janet
    Wang, Yan-Yan
    Rangel, Angelica
    Loera, Ana
    Hanlon, Alexandra
    Lozano, Alicia
    Kovach, Christine
    Gooneratne, Nalaka
    Fry, Liam
    Allen, Richard
    RESEARCH IN GERONTOLOGICAL NURSING, 2020, 13 (06) : 280 - +
12345